The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Adverse Effects of Immunoglobulin Therapy
Open accessAbstract
Immunoglobulin has been widely used in a variety of diseases, including primary and secondary immunodeficiency diseases, neuromuscular diseases, and Kawasaki disease. Although a large number of clinical trials have demonstrated that immunoglobulin is effective and well tolerated, various adverse effects have been reported. The majority of these events, such as flushing, headache, malaise, fever, chills, fatigue and lethargy, are transient and mild. However, some rare side effects, including renal impairment, thrombosis, arrhythmia, aseptic meningitis, hemolytic anemia, and transfusion-related acute lung injury (TRALI), are serious. These adverse effects are associated with specific immunoglobulin preparations and individual differences. Performing an early assessment of risk factors, infusing at a slow rate, premedicating, and switching from intravenous immunoglobulin (IVIG) to subcutaneous immunoglobulin (SCIG) can minimize these adverse effects. Adverse effects are rarely disabling or fatal, treatment mainly involves supportive measures, and the majority of affected patients have a good prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BRUTON, O. C. (1952) · Pediatrics · doi:10.1542/peds.9.6.722 · Cited by 1,492
Cohn, E. J., Oncley, J. L., Strong, L. E., Hughes, W. L., & Armstrong, S. H. (1944) · Journal of Clinical Investigation · doi:10.1172/jci101508 · Cited by 406
Transfusion-related acute lung injury: a clinical review
Vlaar, A. P., & Juffermans, N. P. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62197-7 · Cited by 383
DEATH DURING THERAPEUTIC STARVATION
Hermann, L. S., & Iversen, M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92649-4 · Cited by 361
van Schaik, I. N., Bril, V., van Geloven, N., Hartung, H., Lewis, R. A., Sobue, G., Lawo, J., Praus, M., Mielke, O., Durn, B. L., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30378-2 · Cited by 333
Chapel, H. M., Spickett, G. P., Ericson, D., Engl, W., Eibl, M. M., & Bjorkander, J. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1006678312925 · Cited by 328
Rn, A. G., Hammarström, L., Gustafson, R., Nyström, T., Smith, C. I. E., Gustafson, R., Jonsson, E., Gardulf, A., Jonsson, E., Möller, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90346-1 · Cited by 266
Ochs, H. D., Gupta, S., Kiessling, P., Nicolay, U., Berger, M., & the Subcutaneous IgG Study Group (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9021-7 · Cited by 260
Complications of intravenous immune globulin treatment in neurologic disease
Brannagan, T. H., Nagle, K. J., Lange, D. J., & Rowland, L. P. (1996) · Neurology · doi:10.1212/wnl.47.3.674 · Cited by 213
Oaklander, A. L., Lunn, M. P., Hughes, R. A., van Schaik, I. N., Frost, C., & Chalk, C. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010369.pub2 · Cited by 199
Intravenous immune globulins: an update for clinicians
Knezevic‐Maramica, I., & Kruskall, M. S. (2003) · Transfusion · doi:10.1046/j.1537-2995.2003.00519.x · Cited by 171
Chen, S., Dong, Y., Yin, Y., & Krucoff, M. W. (2012) · Heart · doi:10.1136/heartjnl-2012-302126 · Cited by 153
Hospital-Associated Venous Thromboembolism in Children: Incidence and Clinical Characteristics
Takemoto, C. M., Sohi, S., Desai, K., Bharaj, R., Khanna, A., McFarland, S., Klaus, S. A., Irshad, A., Goldenberg, N. A., Strouse, J. J., et al. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.10.025 · Cited by 148
Severinsen, M. T., Engebjerg, M. C., Farkas, D. K., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08418.x · Cited by 147
A RANDOMISED TRIAL OF ORAL GAMMAGLOBULIN IN LOW-BIRTH-WEIGHT INFANTS INFECTED WITH ROTAVIRUS
BARNES, G. L., Hewson, P. H., Mclellan, J. A., Doyle, L. W., Knoches, A. M. L., & Kitchen, W. H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92496-5 · Cited by 146
Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency
Berger, M. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.01.008 · Cited by 141
Adverse Effects of Intravenous Immunoglobulin Therapy
Nydegger, U. E., & Sturzenegger, M. (1999) · Drug Safety · doi:10.2165/00002018-199921030-00003 · Cited by 141
Cherin, P., Marié, I., Michallet, M., Pelus, E., Dantal, J., Crave, J., Delain, J.-C., & Viallard, J. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.09.002 · Cited by 139
Intravenous immunoglobulin and the kidney—a two-edged sword
Orbach, H., Tishler, M., & Shoenfeld, Y. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2004.06.003 · Cited by 134
History of Immunoglobulin Replacement
Eibl, M. M. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.06.004 · Cited by 132
Imbach, P. A., Barandun, S., Baumgärtner, C., Hirt, A., Hofer, F., & Wagner, H. P. (1981) · PubMed · Cited by 125
The Production Processes and Biological Effects of Intravenous Immunoglobulin
Afonso, A. B., & Joao, C. M. (2016) · Biomolecules · doi:10.3390/biom6010015 · Cited by 115
Berger, M., Rojavin, M. A., Kiessling, P. C., & Zenker, O. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.01.006 · Cited by 113
Foster, J. P., Seth, R., & Cole, M. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001816.pub3 · Cited by 111
Subcutaneous immunoglobulin therapy for multifocal motor neuropathy
Eftimov, F., Vermeulen, M., de Haan, R. J., van den Berg, L. H., & van Schaik, I. N. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00218.x · Cited by 111
Adverse Effects of Intravenous Immunoglobulin Therapy in 56 Patients with Autoimmune Diseases
Sherer, Y., Levy, Y. M., Langevitz, P., Rauova, L., Fabrizzi, F., & Shoenfeld, Y. (2001) · Pharmacology · doi:10.1159/000056085 · Cited by 105
Daniel, G. W., Menis, M. D., Sridhar, G., Scott, D. E., Wallace, A. E., Ovanesov, M. V., Golding, B., Anderson, S. A., Epstein, J. S., Martin, D., et al. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03589.x · Cited by 100
Renal insufficiency after intravenous immune globulin therapy
Cayco, A. V., Perazella, M. A., & Hayslett, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8111788 · Cited by 94
Berger, M., Murphy, E., Riley, P., & Bergman, G. E. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181eba6ea · Cited by 94
Nephrotoxicity of intravenous immunoglobulin
Levy, J. B. (2000) · QJM · doi:10.1093/qjmed/93.11.751 · Cited by 85
Moulis, G., Audemard‐Verger, A., Arnaud, L., Luxembourger, C., Montastruc, F., Găman, A. M., Svenungsson, E., Ruggeri, M., Mahévas, M., Gerfaud‐Valentin, M., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.11.001 · Cited by 84
Pulmonary and renal toxicity of intravenous immunoglobulin.
Rault, R., Piraino, B., Johnston, J. R., & Oral, A. (1991) · PubMed · Cited by 73
Vivaglobin® Study Group, Hoffmann, F., Grimbacher, B., Thiel, J., Peter, H. H., & Belohradsky, B. H. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-6-238 · Cited by 67
Hansen‐Schmidt, S., Silomon, J., & Keller, F. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90505-3 · Cited by 64
Qin, Y., Zhou, T., Su, L., Lei, F.-Y., Zhao, Y.-J., & Huang, W.-F. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3283401490 · Cited by 58
Bharath, V., Eckert, K., Kang, M. S., Chin-Yee, I. H., & Hsia, C. C. (2015) · Transfusion · doi:10.1111/trf.13200 · Cited by 55
Subcutaneous immunoglobulin in myasthenia gravis exacerbation: A prospective, open-label trial
Beecher, G., Anderson, D., & Siddiqi, Z. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004365 · Cited by 51
Intravenous immunoglobulin for the treatment of childhood encephalitis
Iro, M. A., Martin, N. G., Absoud, M., & Pollard, A. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011367.pub2 · Cited by 44
Daphnis, E. K., Stylianou, K., Alexandrakis, M. G., Xylouri, I., Vardaki, E. A., Stratigis, S., & Kyriazis, J. (2007) · Nephron Clinical Practice · doi:10.1159/000104424 · Cited by 43
Aghamohammadi, A., Farhoudi, A., Nikzad, M., Moin, M., Pourpak, Z., Rezaei, N., Gharagozlou, M., Movahedi, M., Atarod, L., Ahmadiafshar, A., et al. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61711-5 · Cited by 42
Kanegane, H., Imai, K., Yamada, M., Takada, H., Ariga, T., Bexon, M., Rojavin, M. A., Hu, W., Kobayashi, M., Lawo, J., et al. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9985-z · Cited by 37
Pecoraro, A., Crescenzi, L., Granata, F., Genovese, A., & Spadaro, G. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.09.005 · Cited by 36
Souayah, N., Hasan, A., Khan, H. M. R., Yacoub, H. A., & Jafri, M. (2011) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0b013e3182212589 · Cited by 34
Thépot, S., Malphettes, M., Gardeur, A., Galicier, L., Asli, B., Karlin, L., Gérard, L., Laumont, R., Doize, M.-L., Arnulf, B., et al. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9417-2 · Cited by 30
Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia
Spadaro, G., Pecoraro, A., Renzo, A. D., Pepa, R. D., & Genovese, A. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.04.001 · Cited by 29
Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure
Bentley, P., Rosso, M., Sadnicka, A., Israeli‐Korn, S., Laffan, M., & Sharma, P. K. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01287.x · Cited by 25
Evidence-Based Strategies to Reduce Intravenous Immunoglobulin–Induced Headaches
Thornby, K., Henneman, A., & Brown, D. A. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015576362 · Cited by 24
Fokkink, W. R., Koch, B., Ramakers, C. R. B., van Doorn, P. A., van Gelder, T., & Jacobs, B. C. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.693 · Cited by 21
Oral immunoglobulin for the prevention of rotavirus infection in low birth weight infants
Pammi, M., & Haque, K. N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003740.pub2 · Cited by 19
Immediate adverse reactions to intravenous immunoglobulin in children: a single center experience.
Kaba, S., Keskindemirci, G., Aydoğmuş, Ç., Şiraneci, R., & Çipe, F. (2017) · PubMed · Cited by 17
Wright, S. E., Shaikh, Z. H., Castillo-Lugo, J. A., & Tanrıöver, B. (2008) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00294.x · Cited by 16
Kim, A. S., & Broide, D. H. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.11.009 · Cited by 8
Bilateral uveitis following intravenous immunoglobulin administration
Kocak, E. D., Wang, B. Z., & Hall, A. J. H. (2017) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2017.03.005 · Cited by 7
Uygur-Kucukseymen, E., Yüksel, B., Genç, F. N., Göksu, E. Ö., Yildiz, S., & Gömceli, Y. B. (2017) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000236 · Cited by 7
Cited by
Postwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R. (2023) · Medical Oncology · doi:10.1007/s12032-023-02201-8 · Cited by 26
Metadata
- Authors
- Guo, Y., Tian, X., Wang, X., & Xiao, Z.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-06-08
- Volume
- 9
- Pages
- 1299-1299
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2804781394
- Cited by
- 398
- References
- 54
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.